Natascha Gagnon

Montreal, QC H3T1E2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Hepatic inflammation after exposure to a mixture of low-dose arsenic and cadmium in a murine model of fatty liver disease.

Hepatic inflammation after exposure to a mixture of low-dose arsenic and cadmium in a murine model of fatty liver disease.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: June 12, 2026

mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway.

mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway.

Journal: Cell death & disease

Published: November 10, 2025

Measurement of Reactor Antineutrino Oscillation at SNO.

Measurement of Reactor Antineutrino Oscillation at SNO.

Journal: Physical review letters

Published: May 07, 2025

The CCL17-CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

The CCL17-CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

Journal: Cancer immunology research

Published: May 07, 2025

Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity.

Lack of phospho-eIF4E worsens experimental colitis by inhibiting Treg suppressive activity.

Journal: Journal of inflammation (London, England)

Published: April 28, 2025

RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR.

RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR.

Journal: Cell death and differentiation

Published: April 16, 2025

Mouse nephron formation is impaired by moderate dose arsenical exposure.

Mouse nephron formation is impaired by moderate dose arsenical exposure.

Journal: Toxicology and applied pharmacology

Published: October 30, 2024

Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.

Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.

Journal: Science advances

Published: September 13, 2024

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Journal: The Journal of clinical investigation

Published: May 01, 2024

Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments.

Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments.

Journal: Cell & bioscience

Published: October 18, 2023

Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma.

Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma.

Journal: The Journal of investigative dermatology

Published: August 28, 2023

In vitro and in vivo approaches to assess atherosclerosis following exposure to low-dose mixtures of arsenic and cadmium.

In vitro and in vivo approaches to assess atherosclerosis following exposure to low-dose mixtures of arsenic and cadmium.

Journal: Toxicology and applied pharmacology

Published: August 17, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026